The Parkinson's disease market-Reference-Cited by-同舟云学术

The Parkinson's disease market

Published:2011-08 Issue:8 Volume:10 Page:571-572
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Huynh Trung

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.nature.com/articles/nrd3515.pdf

Reference3 articles.

1. Datamonitor. Epidemiology: Parkinson's Disease — the aging population will cause the prevalence of Parkinson's disease to continue to grow. HC00039–001 (2011).

2. Olanow, C. W., Watts, R. L. & Koller W. C. (2001). An algorithm (decision tree) for the management of Parkinson's disease. Neurology, 56 (Suppl. 5), 1–88 (2011).

3. Olanow, C. W. et al. A double-blind delayed-start trial of rasagiline in Parkinson's disease. N. Engl. J. Med. 361, 1268–1278 (2009).

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidoreductase enzymes: Characteristics, applications, and challenges as a biocatalyst;Biotechnology and Applied Biochemistry;2023-09-27

2. Anti-parkinsonian activity of the adenosine A2A receptor antagonist/inverse agonist KW-6356 as monotherapy in MPTP-treated common marmosets;European Journal of Pharmacology;2023-07

3. In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A_2AReceptor Antagonist/Inverse Agonist;Molecular Pharmacology;2023-03-09

4. Contribution of syndecans to cellular uptake and fibrillation of α-synuclein and tau;Scientific Reports;2019-11-12

5. Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson’s Disease Models;International Journal of Molecular Sciences;2019-10-21